TP53 and adenocarcinoma: ACRG classification also supports the good prognosis of EBVaGC, since EBVaGC is more frequently included in the microsatellite stable/TP53+ (MSS/P53+) subtype which, together with the microsatellite-instable (MSI) adenocarcinomas, showed the best survival among the overall GC [39].